eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 14
Review paper

Is left ventricular hypertrophy a friend or foe of patients with aortic stenosis?

Cecilla Davies, Katherine Zerebiec, Agnieszka Rożanowska, Ewa Czestkowska, Dorota Długosz, Bernadeta Chyrchel, Andrzej Surdacki

Adv Interv Cardiol 2018; 14, 4 (54): 328–337
Online publish date: 2018/10/03
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Left ventricular hypertrophy (LVH) is traditionally considered a physiological compensatory response to LV pressure overload, such as hypertension and aortic stenosis (AS), in an effort to maintain LV systolic function in the face of an increased afterload. According to the Laplace law, LV wall thickening lowers LV wall stress, which in turn would be helpful to preserve LV systolic performance. However, numerous studies have challenged the notion of LVH as a putative beneficial adaptive mechanism. In fact, the magnitude of LVH is associated with higher cardiovascular morbidity and mortality, especially when LVH is disproportionate to LV afterload. We have briefly reviewed: first, the importance of non-valvular factors, beyond AS severity, for total LV afterload and symptomatic status in AS patients; second, associations of excessive LVH with LV dysfunction and adverse outcome in AS; third, prognostic relevance of the presence or absence of pre-operative LVH in patients referred for aortic valve surgery; fourth, time course, determinants and prognostic implications of LVH regression and LV function recovery after surgical valve replacement and transcatheter aortic valve implantation (TAVI) with a focus on TAVI-specific effects; fifth, the potential of medical therapy to modulate LVH before and after surgical or interventional treatment for severe AS, a condition perceived as a relative contraindication to renin-angiotensin system blockade.

aortic valve stenosis, cardiac valve surgery, left ventricular function, left ventricular hypertrophy, prognosis, transcatheter aortic valve implantation

O’Rourke MF, Staessen JA, Vlachopoulos C, et al. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15: 426-44.
Grodzicki T, Messerli FH. The heart in the hypertensive elderly. J Hum Hypertens 1998; 12: 593-7.
De Simone G, Kitzman DW, Palmieri V, et al. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study. Am J Hypertens 2004; 17: 828-33.
Palmieri V, de Simone G, Roman MJ, et al. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass. Hypertension 1999; 34: 1032-40.
Palmieri V, Wachtell K, Gerdts E, et al. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study. Am Heart J 2001; 141: 784-91.
Galderisi M, de Simone G, Cicala S, et al. Coronary flow reserve in hypertensive patients with appropriate or inappropriate left ventricular mass. J Hypertens 2003; 21: 2183-8.
De Simone G, Verdecchia P, Pede S, et al. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension 2002; 40: 470-6.
De Simone G, Gottdiener JS, Chinali M, Maurer MS. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J 2008; 29: 741-7.
Shim CY. Arterial-cardiac interaction: the concept and implications. J Cardiovasc Ultrasound 2011; 19: 62-6.
Briand M, Dumesnil JG, Kadem L, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol 2005; 46: 291-8.
Dulgheru R, Magne J, Capoulade R, et al. Impact of global hemodynamic load on exercise capacity in aortic stenosis. Int J Cardiol 2013; 168: 2272-7.
Ramamurthi A, Pandian NG, Gangadharamurthy D, et al. The syndrome of degenerative calcific aortic stenosis: prevalence of multiple pathophysiologic disorders in association with valvular stenosis and their implications. Echocardiography 2013; 30: 1-7.
Rajani R, Rimington H, Nabeebaccus A, et al. Asymptomatic aortic stenosis: the influence of the systemic vasculature on exercise time. J Am Soc Echocardiogr 2012; 25: 613-9.
Kruszelnicka O, Chmiela M, Bobrowska, et al. Depressed systemic arterial compliance is associated with the severity of heart failure symptoms in moderate-to-severe aortic atenosis: a cross-sectional retrospective study. Int J Med Sci 2015; 12: 552-8.
Tongue AG, Dumesnil JG, Laforest I, et al. Left ventricular longitudinal shortening in patients with aortic stenosis: relationship with symptomatic status. J Heart Valve Dis 2003; 12: 142-9.
Dahl JS, Christensen NL, Videbæk L, et al. Left ventricular diastolic function is associated with symptom status in severe aortic valve stenosis. Circ Cardiovasc Imaging 2014; 7: 142-8.
Dalsgaard M, Kjaergaard J, Pecini R, et al. Predictors of exercise capacity and symptoms in severe aortic stenosis. Eur J Echocardiogr 2010; 11: 482-7.
Gerdts E, Rossebø AB, Pedersen TR, et al. Relation of left ventricular mass to prognosis in initially asymptomatic mild to moderate aortic valve stenosis. Circ Cardiovasc Imaging 2015; 8: e003644.
De Simone G, Devereux RB, Kimball TR, et al. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 1998; 31: 1077-82.
Palmieri V, Okin PM, de Simone G, et al. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. J Hypertens 2007; 25: 1079-85.
Cioffi G, de Simone G, Cramariuc D, et al. Inappropriately high left-ventricular mass in asymptomatic mild-moderate aortic stenosis. J Hypertens 2012; 30: 421-8.
Mureddu GF, Pasanisi F, Palmieri V, et al. Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy. J Hypertens 2001; 19: 1113-9.
Lund BP, Gohlke-Bärwolf C, Cramariuc D, et al. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy). Am J Cardiol 2010; 105: 1456-60.
Pagé A, Dumesnil JG, Clavel MA, et al.; ASTRONOMER Investigators. Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). J Am Coll Cardiol 2010; 55: 1867-74.
Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995; 26: 195-202.
Aurigemma GP, Devereux RB, de Simone G, et al. Myocardial function and geometry in hypertensive subjects with low levels of afterload. Am Heart J 2002; 143: 546-51.
Cioffi G, Faggiano P, Vizzardi E, et al. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart 2011; 97: 301-7.
Orsinelli DA, Aurigemma GP, Battista S, et al. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high risk subgroup identified by preoperative relative wall thickness. J Am Coll Cardiol 1993; 22: 1679-83.
Duncan AI, Lowe BS, Garcia MJ, et al. Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. Ann Thorac Surg 2008; 85: 2030-9.
Debry N, Maréchaux S, Rusinaru D, et al. Prognostic significance of left ventricular concentric remodelling in patients with aortic stenosis. Arch Cardiovasc Dis 2017; 110: 26-34.
Seiler C, Jenni R. Severe aortic stenosis without left ventricular hypertrophy: prevalence, predictors, and short-term follow up after aortic valve replacement. Heart 1996; 76: 250-5.
Barasch E, Kahn J, Petillo F, Pollack S, et al. Absence of left ventricular hypertrophy in severe isolated aortic stenosis and preserved left ventricular systolic function. J Heart Valve Dis 2014; 23: 1-8.
De Simone G, Palmieri V, Koren MJ, et al. Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension. J Hypertens 2001; 19: 119-25.
Carroll JD, Carroll EP, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992; 86: 1099-107.
Villari B, Campbell SE, Schneider J, et al. Sex-dependent differences in left ventricular function and structure in chronic pressure overload. Eur Heart J 1995; 16: 1410-9.
Petrov G, Regitz-Zagrosek V, Lehmkuhl E, et al. Regression of myocardial hypertrophy after aortic valve replacement: faster in women? Circulation 2010; 122 (11 Suppl): S23-8.
Petrov G, Dworatzek E, Schulze TM, et al. Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement. JACC Cardiovasc Imaging 2014; 7: 1073-80.
Gavina C, Falcão-Pires I, Pinho P, et al. Relevance of residual left ventricular hypertrophy after surgery for isolated aortic stenosis. Eur J Cardiothorac Surg 2016; 49: 952-9.
Sharma UC, Barenbrug P, Pokharel S, et al. Systematic review of the outcome of aortic valve replacement in patients with aortic stenosis. Ann Thorac Surg 2004; 78: 90-5.
Ali A, Patel A, Ali Z, et al. Enhanced left ventricular mass regression after aortic valve replacement in patients with aortic stenosis is associated with improved long-term survival. J Thorac Cardiovasc Surg 2011; 142: 285-91.
Beach JM, Mihaljevic T, Rajeswaran J, et al. Ventricular hypertrophy and left atrial dilatation persist and are associated with reduced survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 2014; 147: 362-9.
Hatani T, Kitai T, Murai R, et al. Associations of residual left ventricular and left atrial remodeling with clinical outcomes in patients after aortic valve replacement for severe aortic stenosis. J Cardiol 2016; 68: 241-7.
Une D, Mesana L, Chan V, et al. Clinical impact of changes in left ventricular function after aortic valve replacement: analysis from 3112 patients. Circulation 2015; 132: 741-7.
Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-98.
Hahn RT, Pibarot P, Stewart WJ, et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (Placement of Aortic Transcatheter Valves). J Am Coll Cardiol 2013; 61: 2514-21.
Al-Hawwas M, Marmagkiolis K, Mehta JL. The impact of transcatheter aortic valve implantation and surgical aortic valve replacement on left ventricular remodeling. Am J Cardiol 2017; 120: 1198-202.
Douglas PS, Hahn RT, Pibarot P, et al. Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial. J Am Soc Echocardiogr 2015; 28: 210-7.
Pibarot P, Weissman NJ, Stewart WJ, et al. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort-A analysis. J Am Coll Cardiol 2014; 64: 1323-34.
Lindman BR, Stewart WJ, Pibarot P, et al. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. JACC Cardiovasc Interv 2014; 7: 662-73.
Panoulas VF, Ruparelia N, Franks R, et al. The impact of gender on outcomes following transcatheter aortic valve implantation: true effect or bias? J Heart Valve Dis 2016; 25: 552-6.
Williams M, Kodali SK, Hahn RT, et al. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 2014; 63: 1522-8.
Rymuza B, Zbroński K, Ścisło P, et al. Left ventricular remodelling pattern and its relation to clinical outcomes in patients with severe aortic stenosis treated with transcatheter aortic valve implantation. Adv Interv Cardiol 2017; 13: 288-94.
Tzikas A, Geleijnse ML, Van Mieghem NM, et al. Left ventricular mass regression one year after transcatheter aortic valve implantation. Ann Thorac Surg 2011; 91: 685-91.
Nucifora G, Tantiongco JP, Crouch G, et al. Changes of left ventricular mechanics after trans-catheter aortic valve implantation and surgical aortic valve replacement for severe aortic stenosis: a tissue-tracking cardiac magnetic resonance study. Int J Cardiol 2017; 228: 184-90.
Costantino MF, Galderisi M, Dores E, et al. Parallel improvement of left ventricular geometry and filling pressure after transcatheter aortic valve implantation in high risk aortic stenosis: comparison with major prosthetic surgery by standard echo Doppler evaluation. Cardiovasc Ultrasound 2013; 11: 18.
Kjeldsen SE, Strand A, Julius S, Okin PM. Mechanism of angiotensin II type 1 receptor blocker action in the regression of left ventricular hypertrophy. J Clin Hypertens (Greenwich) 2006; 8: 487-92.
Fielitz J, Hein S, Mitrovic V, et al. Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. J Am Coll Cardiol 2001; 37: 1443-9.
Weidemann F, Herrmann S, Störk S, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009; 120: 577-84.
Nadir MA, Wei L, Elder DH, et al. Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. J Am Coll Cardiol 2011; 58: 570-6.
Goh SS, Sia CH, Ngiam NJ, et al. Effect of renin-angiotensin blockers on left ventricular remodeling in severe aortic stenosis. Am J Cardiol 2017; 119: 1839-45.
Bang CN, Greve AM, Køber L, et al. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis. Int J Cardiol 2014; 175: 492-8.
Dlugosz D, Bolt K, Sam WS, et al. Excessive left ventricular hypertrophy in moderate degenerative aortic stenosis: an ineffective compensatory mechanism triggered by primary myocardial dysfunction and enhanced by concomitant mild renal impairment? Kardiol Pol 2018 (in press).
Ochiai T, Saito S, Yamanaka F, et al. Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation. Heart 2018; 104: 644-51.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe